Gregory Rosenblatt
Overview
Explore the profile of Gregory Rosenblatt including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
115
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hu E, An J, Gersten A, Wu N, Kawachi N, Zhu J, et al.
Front Oncol
. 2025 Mar;
15:1539782.
PMID: 40046621
The integration of viral DNA into the human genome is a critical event in the pathogenesis of various cancers. This process leads to genomic instability, disrupts cellular regulatory mechanisms, and...
2.
Li D, Lopez A, Shrivastava N, Chan W, Thomas C, Burk R, et al.
Oral Oncol
. 2024 Oct;
159:107069.
PMID: 39423550
Evasion of apoptosis promotes tumor survival and contributes to resistance to cancer therapeutics in head and neck squamous cell carcinoma (HNSCC). Our recent work has demonstrated that HNSCC's highly express...
3.
Ow T, Mehta V, Li D, Thomas C, Shrivastava N, Kawachi N, et al.
Laryngoscope
. 2024 Jan;
134(6):2748-2756.
PMID: 38288866
Objective: To establish and characterize a diverse library of head and neck squamous cell cancer (HNSCC) cultures using conditional reprogramming (CR). Methods: Patients enrolled on an IRB-approved protocol to generate...
4.
Kroll M, Bi C, Salm A, Szymanski J, Goldstein D, Wolgast L, et al.
Arch Pathol Lab Med
. 2023 Jun;
147(10):1109-1118.
PMID: 37338199
Context.—: Disease courses in COVID-19 patients vary widely. Prediction of disease severity on initial diagnosis would aid appropriate therapy, but few studies include data from initial diagnosis. Objective.—: To develop...
5.
Li D, Thomas C, Shrivastava N, Gersten A, Gadsden N, Schlecht N, et al.
J Med Virol
. 2022 Dec;
95(2):e28388.
PMID: 36477880
Most laboratory models of head and neck squamous cell cancer (HNSCC) rely on established immortalized cell lines, which carry inherent bias due to selection and clonality. We established a robust...
6.
Foksinska A, Crowder C, Crouse A, Henrikson J, Byrd W, Rosenblatt G, et al.
Front Artif Intell
. 2022 Oct;
5:910216.
PMID: 36248623
There are over 6,000 different rare diseases estimated to impact 300 million people worldwide. As genetic testing becomes more common practice in the clinical setting, the number of rare disease...
7.
Ponduri A, Liao D, Schlecht N, Rosenblatt G, Prystowsky M, Kabarriti R, et al.
J Natl Compr Canc Netw
. 2021 Sep;
:1-7.
PMID: 34555804
Background: Nonadherence to NCCN Guidelines during time from surgery to postoperative radiotherapy (S-PORT) can alter survival outcomes in head and neck squamous cell carcinomna (HNSCC). There is a need to...
8.
Ow T, Thomas C, Fulcher C, Chen J, Lopez A, Reyna D, et al.
Laryngoscope
. 2020 May;
130(8):E458-E459.
PMID: 32421206
No abstract available.
9.
Ow T, Thomas C, Fulcher C, Chen J, Lopez A, Reyna D, et al.
Laryngoscope
. 2020 Jan;
130(11):2643-2649.
PMID: 31894587
Objectives: To evaluate BCL-2 family signaling molecules in head and neck squamous cell carcinoma (HNSCC) and examine the ability of therapeutic agents with variable mechanisms of action to induce apoptosis...
10.
Liao D, Schlecht N, Rosenblatt G, Kinkhabwala C, Leonard J, Ference R, et al.
JAMA Otolaryngol Head Neck Surg
. 2019 Sep;
145(11):1001-1009.
PMID: 31513264
Importance: Delay in time to treatment initiation (TTI) can alter survival and oncologic outcomes. There is a need to characterize these consequences and identify risk factors and reasons for treatment...